Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, TX 77843-4466, United States.
Antiviral Res. 2012 Aug;95(2):150-8. doi: 10.1016/j.antiviral.2012.05.007. Epub 2012 May 26.
Vesicular stomatitis virus (VSV) causes great economic impact to livestock industry and is a prototype for studying non-segmented negative-stranded RNA (NSNR) viruses. In this study, we evaluated the antiviral potential of unique short-hairpin RNA (shRNA) targeting genes that form the ribonuclear protein (RNP) complex of VSV serotype Indiana (VSIV). We used lentiviral vectors to construct cell lines that stably expressed one of seven shRNAs targeting the RNP genes of VSIV, namely nucleocapsid (N), phosphoprotein (P), or polymerase (L). We reported two N-shRNA sequences targeting the 5' or 3' end of N that significantly reduced N, P, and L viral transcripts (p<0.001), reduced viral protein expression, and reduced the viral particles shed in Vero cells (p<0.01). When we analyzed the sequence diversity in the target region of this N-shRNA from two field isolates, we detected a single base substitution outside the seed region. We also reported five other shRNA sequences targeting components of the viral RNA that significantly reduce N, P, and L viral transcripts (p<0.001) but failed to efficiently impair viral replication. The differences in the efficiency of the shRNAs tested were not due to mismatches within the target region in the genome of VSIV. Although partial silencing of viral transcripts by single shRNAs impaired but did not block VSIV replication, the combination of the shRNAs identified here into a multiple shRNA vector may result in inhibition of viral replication. These data contribute to ongoing development of RNAi-based technologies to combat viral diseases.
水疱性口炎病毒(VSV)给畜牧业造成了巨大的经济影响,是研究无节段负链 RNA(NSNR)病毒的原型。在本研究中,我们评估了针对 VSV 印第安纳血清型(VSIV)核糖核蛋白(RNP)复合物基因的独特短发夹 RNA(shRNA)的抗病毒潜力。我们使用慢病毒载体构建了稳定表达七种针对 VSIV 的 RNP 基因的 shRNA 之一的细胞系,这些基因分别是核衣壳(N)、磷蛋白(P)或聚合酶(L)。我们报道了两种靶向 N 蛋白 5'或 3'端的 N-shRNA 序列,它们显著降低了 N、P 和 L 病毒转录物(p<0.001),降低了病毒蛋白表达,并减少了 Vero 细胞中释放的病毒颗粒(p<0.01)。当我们分析来自两个田间分离株的该 N-shRNA 靶区的序列多样性时,我们在种子区外检测到一个单一碱基取代。我们还报道了其他五种靶向病毒 RNA 成分的 shRNA 序列,它们显著降低了 N、P 和 L 病毒转录物(p<0.001),但未能有效抑制病毒复制。所测试的 shRNA 的效率差异不是由于 VSIV 基因组中靶区的错配造成的。尽管单个 shRNA 对病毒转录物的部分沉默削弱了但没有阻断 VSIV 复制,但将这里鉴定的 shRNA 组合到多 shRNA 载体中可能会抑制病毒复制。这些数据为基于 RNAi 的技术对抗病毒疾病的持续发展做出了贡献。